Granzyme B nanoreporter for early monitoring of tumor response to immunotherapy

Despite recent advancements in cancer immunotherapy, accurate monitoring of its efficacy is challenging due to heterogeneous immune responses. Conventional imaging techniques lack the sensitivity and specificity for early response assessment. In this study, we designed a granzyme B (GrB) nanoreporte...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Anh, Ramesh, Anujan, Kumar, Sahana, Nandi, Dipika, Brouillard, Anthony, Wells, Alexandria, Pobezinsky, Leonid, Osborne, Barbara, Kulkarni, Ashish A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852386/
https://www.ncbi.nlm.nih.gov/pubmed/33008894
http://dx.doi.org/10.1126/sciadv.abc2777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852386/
https://www.ncbi.nlm.nih.gov/pubmed/33008894
http://dx.doi.org/10.1126/sciadv.abc2777

Ejemplares similares